188 related articles for article (PubMed ID: 31195022)
1. Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients.
Koh HK; Chai ZT; Tay HW; Fook-Chong S; Choo KJL; Oh CC; Yeo YW; Koh HY; Pang SM; Lee HY
J Am Acad Dermatol; 2019 Sep; 81(3):686-693. PubMed ID: 31195022
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures.
de Prost N; Ingen-Housz-Oro S; Duong TA; Valeyrie-Allanore L; Legrand P; Wolkenstein P; Brochard L; Brun-Buisson C; Roujeau JC
Medicine (Baltimore); 2010 Jan; 89(1):28-36. PubMed ID: 20075702
[TBL] [Abstract][Full Text] [Related]
3. The age of procalcitonin: potential pitfalls in critically ill patients with SJS/TEN. A comment on "Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients".
Jacobsen AA; Pearson DR
J Am Acad Dermatol; 2020 Jun; 82(6):e247. PubMed ID: 32092376
[No Abstract] [Full Text] [Related]
4. Reply to: "The age of procalcitonin: Potential pitfalls in critically ill patients with SJS/TEN. A comment on 'Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients'".
Koh HK; Lee HY
J Am Acad Dermatol; 2020 Jun; 82(6):e249. PubMed ID: 32092373
[No Abstract] [Full Text] [Related]
5. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Tian XB; Liu W; Zhang LX
J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
[TBL] [Abstract][Full Text] [Related]
6. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
[TBL] [Abstract][Full Text] [Related]
7. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
[TBL] [Abstract][Full Text] [Related]
10. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
11. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
[TBL] [Abstract][Full Text] [Related]
12. Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: A retrospective observational cohort study of 98 cases.
Lecadet A; Woerther PL; Hua C; Colin A; Gomart C; Decousser JW; Mekontso Dessap A; Wolkenstein P; Chosidow O; de Prost N; Ingen-Housz-Oro S
J Am Acad Dermatol; 2019 Aug; 81(2):342-347. PubMed ID: 30890340
[TBL] [Abstract][Full Text] [Related]
13. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
[TBL] [Abstract][Full Text] [Related]
16. Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chen CB; Hsu TH; Chung-Yee Hui R; Lu CW; Chen WT; Chiang PH; Wang CW; Chuang SS; Yang JY; Yang SY; Chang SY; Hsiao YC; Kao KC; Hu HC; Wu TS; Hsu CW; Hui-Kang Ma D; Chen SY; Tian YC; Cheng CY; Chen CH; Chi MH; Wu MY; Liu RF; Wang CH; Chang YC; Lin JY; Ho HC; Yu-Wei Lin Y; Chang CJ; Lin YJ; Ku CL; Hung SI; Chung WH;
J Am Acad Dermatol; 2021 Jun; 84(6):1782-1791. PubMed ID: 32828861
[TBL] [Abstract][Full Text] [Related]
17. The use of porcine xenografts in patients with toxic epidermal necrolysis.
Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA
Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163
[TBL] [Abstract][Full Text] [Related]
18. Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sotozono C; Ueta M; Nakatani E; Kitami A; Watanabe H; Sueki H; Iijima M; Aihara M; Ikezawa Z; Aihara Y; Kano Y; Shiohara T; Tohyama M; Shirakata Y; Kaneda H; Fukushima M; Kinoshita S; Hashimoto K;
Am J Ophthalmol; 2015 Aug; 160(2):228-237.e2. PubMed ID: 25979679
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the clinical features and prognostic influencing factors of toxic epidermal necrolysis].
Hu ZX; Bian HN; Ma D; Luo HM; Sun CW; Lai W
Zhonghua Shao Shang Za Zhi; 2021 Aug; 37(8):738-746. PubMed ID: 34404158
[No Abstract] [Full Text] [Related]
20. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
